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Although infrequently diagnosed in the United States, 
leptospirosis is a notable reemerging infectious disease 
throughout developing countries. Until 1995, when the dis-
ease was eliminated from the US list of nationally notiﬁ  able 
diseases, Hawaii led the nation in reported annual incidence 
rates. Leptospirosis remains a notiﬁ  able disease in Hawaii. 
To ascertain the status of leptospirosis in Hawaii since the 
most recent US report in 2002, we reviewed 1999–2008 
data obtained from case investigation reports by the Hawaii 
State Department of Health. Of the 345 case reports related 
to in-state exposures, 198 (57%) were laboratory conﬁ  rmed. 
Our ﬁ  ndings indicate a change in seasonal disease occur-
rence from summer to winter and in the infective serogroup 
from Icterohemorrhagiae to Australis. Also, during the past 
20 years, recreational exposures have plateaued, while oc-
cupational exposures have increased. Ongoing surveillance 
is needed to clarify and track the dynamic epidemiology of 
this widespread zoonosis. 
L
eptospirosis is considered the most globally widespread 
zoonotic illness; it has been classiﬁ  ed as an emerging 
or reemerging infectious disease by the World Health Or-
ganization (1) and the US Centers for Disease Control and 
Prevention (CDC) (2). Most frequently recognized as a dis-
ease of the developing world (3), leptospirosis was removed 
from the US list of nationally reportable infectious diseases 
in 1995 (4). Before the disease’s removal from national 
surveillance, Hawaii consistently led the nation in reported 
annual incidence rates (5). The state of Hawaii continues 
to include leptospirosis as a notiﬁ  able illness. The last pub-
lished US population-based surveillance report was from 
Hawaii and covered data obtained during 1974–1998 (5). 
This study serves as an update for leptospirosis in Hawaii 
during 1999–2008.
Methods
We reviewed leptospirosis case investigation reports 
by Hawaii Department of Health (HDOH) investigators 
submitted during 1999–2008. These reports were (and 
still are) generated for all reported leptospirosis cases in 
the state. A standardized case investigation form was used, 
which includes demographic, epidemiologic, clinical, and 
laboratory information obtained from patient interviews, 
medical record reviews, and laboratory reports. Research 
for this study was approved by the HDOH Institutional Re-
view Board.
For exposure source to be assessed, incubation periods 
estimated, and exposures classiﬁ  ed, patients were asked 
about high-risk activities that occurred during the 21 days 
before symptom onset. These included exposure to ani-
mals, mud, or potentially contaminated freshwater sources 
involving occupational activities (e.g., farming, ranching), 
recreational activities (e.g., freshwater swimming, hiking), 
or habitational activities (around the home; e.g., garden-
ing, trapping rats). If exposure was continuous or if persons 
had been exposed multiple times, the incubation period was 
considered indeterminate. Ascertainment of exposure clas-
siﬁ  cation involved placing cases into 3 mutually exclusive 
exposure categories: occupational, recreational, or habi-
tational. If exposure activities involved >1 category, the 
exposure classiﬁ  cation was considered indeterminate. Out-
breaks were deﬁ  ned as >2 epidemiologically linked cases.
A patient with a conﬁ  rmed case had a clinically com-
patible illness plus a >4-fold increase in microscopic agglu-
tination test (MAT) titer between acute- and convalescent-
phase serum specimens or isolation of Leptospira spp. from 
a clinical specimen (6,7). All other cases were classiﬁ  ed 
as either probable (clinically compatible illness with MAT 
titer >200 in >1 serum specimens without a 4-fold increase 
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in titer [8]) or suspected (clinically compatible illness with 
less supportive laboratory evidence of infection [e.g., MAT 
titer <200, positive macroscopic slide agglutination test re-
sult, reactive immunoglobulin (Ig) M ELISA, or positive 
indirect hemagglutination assay results]). Only laboratory-
conﬁ  rmed cases in patients whose disease was contracted 
through exposure within the state of Hawaii were included 
in this analysis. MATs were conducted by CDC from Janu-
ary 1999 through November 2004, and by HDOH from De-
cember 2004 through December 2008.
All isolates were sent to CDC for deﬁ  nitive serogroup 
identiﬁ  cation. To determine the presumptive infecting se-
rogroup for serologically conﬁ  rmed cases, MAT titers were 
examined. The highest and most recent titer was presumed 
to be the infecting serogroup. If >1 serogroup had the same 
high titer, the identiﬁ  cation was labeled indeterminate.
To calculate mean annual incidence rates (overall and 
by age, sex, and Hawaii island on which patient was ex-
posed), the numerator was the number of cases for the spec-
iﬁ  ed groups over the 10-year observation period divided 
by 10. The denominator was the overall or relevant group-
speciﬁ  c population estimate from the 2000 US Census (9). 
Data from our earlier 25-year study period, 1974–1998, 
were used for trend analyses (5).
We calculated frequencies, tests for trends, and tests 
for difference using Epi Info version 3.3.2 (CDC, Atlanta, 
GA, USA); p values <0.05 were considered signiﬁ  cant. All 
statistical tests were 2-tailed.
Results
HDOH received 356 leptospirosis case reports; 345 
were related to exposures within the state of Hawaii. The 
11 cases from exposures occurring out of state included 2 
from Guam; 2 from Thailand; and 1 each from Panama, the 
Federated States of Micronesia, Borneo, Okinawa, Malay-
sia, Singapore, and Texas. Of the case reports related to in-
state exposures, 198 (57%) were laboratory conﬁ  rmed, 116 
(34%) were probable, and 31 (9%) were suspected.
The number of conﬁ   rmed cases reported per year 
ranged from 11 to 27 (median 20), and the estimated mean 
annual incidence rate was 1.63 per 100,000 population. 
Mean monthly reported cases were highest from October 
through February (Figure 1). The observed seasonal dis-
ease occurrence for the recent 10-year study period was 
signiﬁ  cantly different from that of the previously reported 
25-year study period; summer cases predominated in the 
latter (p<0.01) (5). 
Case-patients were predominately male (91%), and 
ages ranged from 3 to 76 years (median 38 years). The 
highest age-speciﬁ  c rate was among persons 20–29 years 
of age, and the lowest was among children 0–9 years of 
age. Most cases and the highest incidence rates were re-
lated to exposures on the islands of Kauai and Hawaii 
(Table 1). In addition, cases were most consistently report-
ed from the northeast, windward sides of the islands: Hana-
lei (n = 8) and Wailua (n = 12) on Kauai, Waipio Valley (n 
= 12) and Hilo (n = 17) on Hawaii, and Maunawili Falls (n 
= 13) on Oahu (Figure 2).
We were able to determine exposure classiﬁ  cations for 
177 (89%) of the 198 conﬁ  rmed cases. Recreational expo-
sures accounted for 79 (45%) and were mostly related to 
freshwater swimming, hiking, and camping. Occupational 
exposures accounted for 78 (44%), mostly relating to farm-
ing, speciﬁ  cally, taro farming. Exposures around the home 
accounted for 20 (11%), most commonly, gardening. After 
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Figure 1. Month of onset for 198 laboratory-conﬁ  rmed leptospirosis 
cases, Hawaii, USA, 1999–2008.
Table 1. Sex, age, and island of exposure for 198 case-patients 
with laboratory-confirmed leptospirosis, Hawaii, USA, 1999–2008
Variable
No. (%) 
case-patients
Estimated mean annual 
incidence rate*
Sex
 M  181  (91)  2.97
 F  17  (9)  0.28
Age group, y 
 0–9  1  (1)  0.06
 10–19  24  (12)  1.46
 20–29  48  (24)  2.87
 30–39  31  (16)  1.69
 40–49  38  (19)  2.05
 50–59  36  (18)  2.55
 60–69  15  (8)  1.68
 70–79  5  (3)  0.64
Island
 Hawaii  98  (49)  6.59
 Kauai  47  (24)  8.06
 Oahu  44  (23)  0.50
 Maui  4  (2)  0.34
 Molokai  1  (1)  1.38
 Unknown  4  (2) 
*No. cases/100,000 population. Rate = no. case-patients observed over 10 
years for the specified category divided by 10 divided by specified 
subgroup population estimate from 2000 US Census data (9).Leptospirosis in Hawaii
categorizing cases into 5-year intervals and comparing the 
results with reports from 1989 through 1998 (5), we found 
that recreational exposures remained relatively stable over 
the past 20 years (1989–2008), while occupational expo-
sures actually increased, but the difference was not signiﬁ  -
cant (p = 0.08) (Figure 3). After stratiﬁ  cation by island, a 
signiﬁ  cant increase in occupational exposures was shown 
for the island of Hawaii (p = 0.04). No other trends for ex-
posure classiﬁ  cation were signiﬁ  cant.
Most cases occurred sporadically. One outbreak (>2 
epidemiologically linked cases), which involved 2 land-
scapers, occurred on Kauai in 1999; both cases were labo-
ratory conﬁ  rmed. Another outbreak (2 epidemiologically 
linked cases: 1 conﬁ  rmed, 1 probable) was associated with 
ﬂ  ooding of the University of Hawaii campus on October 
31, 2004, when heavy rains caused an adjacent stream to 
overﬂ  ow its banks (10).
For case-patients with known exposure dates, the me-
dian incubation period was 9 days (range 1–21 days). The 
median duration of illness was 14 days (range 3–90 days). 
A total of 118 (73%) of 161 case-patients, for whom treat-
ment information was available, were hospitalized.
The most frequent signs and symptoms among patients 
who sought treatment were fever, myalgias, headache, nau-
sea, and vomiting. Abnormal urinalysis results were com-
mon; specimens from 78 (73%) of 107 and 71 (68%) of 
105 case-patients showed hematuria and proteinuria, re-
spectively. Results of liver function tests were frequently 
abnormal as well; laboratory results for 109 (74%) of 147 
case-patients showed elevated alanine aminotransferase 
levels (>40 U/L), and 85 (63%) of 134 showed elevated 
total bilirubin levels (>1 mg/dL). The most common he-
matologic anomaly was thrombocytopenia (<140 × 109/L), 
which was observed for 97 (66%) of 146 case-patients 
(Table 2). Initial clinical impression was recorded for 151 
(76%) of 198 patients. The most common initial diagnosis 
was leptospirosis for 114 (75%) of 151 patients.
During the 10-year reporting period, 1 death occurred 
among 198 patients with conﬁ  rmed cases (case-fatality rate 
0.5%). A 23-year-old man who attended college on the 
mainland had been exposed through recreational activities 
while at home in Hawaii during winter break 2003. Symp-
toms developed after he returned to school, and he died in 
January 2004.
Of the 198 patients with conﬁ  rmed infection, 152 (77%) 
received a diagnosis on the basis of serologic testing with 
the MAT, 18 (9%) cases were conﬁ  rmed with culture iso-
lates, and 28 (14%) were conﬁ  rmed by MAT and isolates. 
Forty-three isolates obtained during 2000–2008 were char-
acterized at CDC by molecular and serologic techniques. 
Isolates were grouped into 4 clades based on MAT results 
and pulsed-ﬁ  eld gel electrophoresis: 19 (44%) unknown 
serovar (serogroup Australis), 17 (40%) serovar Icterohe-
morrhagiae (serogroup Icterohemorrhagiae), 4 (9%) sero-
var Ballum (serogroup Ballum), and 3 (7%) of unknown 
serovar (serogroup Bataviae). Cross-agglutination absorp-
tion assay identiﬁ  ed the unknown serovar from serogroup 
Australis as a new serovar closely related to Lora (11).
The most common infecting serogroups (identiﬁ  ed de-
ﬁ  nitively by isolate or presumptively by MAT) were Aus-
tralis (n = 50) and Icterohemorrhagiae (n = 51). Analysis 
for linear trend, after cases were categorized into 5-year in-
tervals and compared with conﬁ  rmed cases reported during 
1974–1998 (5), showed a signiﬁ  cant increase in infections 
attributed to serogroup Australis and a decrease in infec-
tions caused by serogroup Icterohemorrhagiae (p<0.0001 
for each).
Discussion
The most recent 10-year reporting period has demon-
strated a statistically signiﬁ  cant shift in the seasonal occur-
rence of leptospirosis from the drier summer months (5) to 
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Figure 2. Exposure locations associated with the greatest number 
of leptospirosis cases, Hawaii, USA, 1999–2008. 
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Figure 3. Trends in exposure classiﬁ  cation for laboratory-conﬁ  rmed 
leptospirosis cases, Hawaii, USA, 1989–2008.RESEARCH
the wetter winter months. Climatologists have character-
ized the Hawaiian archipelago as having only 2 seasons: 
summer (May through September) and winter (October 
through April). Rainfall and widespread rainstorms are 
most common during the winter months (12).
During the earlier reporting period, 1974–1998, rec-
reationally associated exposures predominated and in-
creased over time; therefore, the summer predominance 
was attributed to the greater likelihood of recreational ex-
posure in the summer. During 1989–2008, the frequency 
of recreational exposures plateaued while frequency of 
occupational exposures seemed to increase. This observed 
change in exposure history might allow seasonal climatic 
effect to have a greater inﬂ  uence on the epidemiology of 
the disease. In addition, taro farming, a recognized high-
risk occupation (5), which had been on the decline, has 
experienced a resurgence relating to renewed interest in 
the cultural importance to native Hawaiians and an aware-
ness of taro’s nutritional value (13). In 2000, Hawaii pro-
duced 7 million pounds of taro, the largest crop yield 
since 1977 (14).
The island distribution of leptospirosis cases remains 
virtually unchanged since our earlier report (5). Kauai, the 
island with the highest annual rainfall and second most 
rural island, had and continues to have the highest inci-
dence rate, followed by Hawaii, the most rural island. As 
in our earlier report, cases were most consistently reported 
from the wetter, windward, northeast sides of each island. 
Notably, climatic changes have been documented for the 
Hawaiian archipelago with signiﬁ  cant trends in increasing 
temperatures (15), decreasing rainfall (16), and increasing 
rain intensity (17) over the past 30 years. The effects of 
climate change on ecosystems are complex, but the poten-
tial for inﬂ  uencing infectious disease patterns has been well 
described (18,19). Temperature and climate changes may 
affect the host animal’s environment, making transmission 
to humans more likely. Increase in rain intensity with re-
sultant ﬂ  ooding is a well-recognized climatic risk factor for 
transmission of Leptospira spp. (20). Flooding was respon-
sible for 1 of the 2 outbreaks during the study period (10).
The predominance of men among case-patients is well 
recognized (21–24) and is virtually unchanged from our 
earlier report (5). This predominance has been explained 
by the tendency of more men to participate in high-risk 
outdoor exposure activities. The low reported age-speciﬁ  c 
case rates in children <10 years of age and highest rates 
among adults 20–50 years of age are also consistently re-
ported (22–24) and similar to our earlier ﬁ  ndings (5).
Our ﬁ  ndings corroborate other large case series that 
show that the most common clinical manifestation of 
leptosporisis are nonspeciﬁ  c signs or symptoms, such as 
fever, headache, and mylagias (5,22,25–27). The case-fa-
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Table 2. Clinical findings for 198 case-patients with laboratory-confirmed leptospirosis, Hawaii, USA, 1999–2008 
Sign, symptoms, and laboratory result  No. (%) patients affected  No. patients with data available 
Sign or symptom 
 Fever  187 (98)  191
 Myalgia  162 (88)  185
 Headache  156  (87)  179
 Nausea  117 (68)  173
 Vomiting  101  (59)  172
 Arthralgia  73  (46)  157
 Diarrhea  79 (46)  171
 Backache  50  (34)  146
 Jaundice  53  (33)  163
  Oliguria or anuria  32 (21)  152
  Conjunctival suffusion  30 (19)  156
  Nuchal rigidity  23 (14)  159
 Pneumonia  13  (8)  154
 Hepatosplenomegaly  8  (6)  140
Laboratory results 
 Renal 
  Hematuria  78  (73)  107
  Proteinuria  71  (68)  105
    Elevated creatinine (>1.5 mg/dL)  60 (51)  118
    Elevated blood urea nitrogen (>20 mg/dL)  68 (50)  136
 Hepatic 
    Elevated alanine aminotransferase (>40 U/L)  109 (74)  147
    Elevated total bilirubin (>1 mg/dL)  85 (63)  134
 Hematologic 
  Thrombocytopenia  (<140  u 10
9/L)  97 (66)  146
    Elevated leukocyte count (>10 u 10
9cells/L)  74 (48)  155
    Decreased hematocrit (<34%)  56 (38)  146Leptospirosis in Hawaii
tality rate (0.5%) is lower than that reported from Brazil 
(25), Barbados (28), Guadeloupe (22), and the Andaman 
Islands (26), but similar to the rates found in our earlier 
study (5) and in a recent case series from France (27). The 
low case-fatality rate in this series may be explained by 
early recognition and initiation of supportive therapy and 
antimicrobial drugs. Other case series may be biased to-
ward recognition and inclusion of only the most severely 
ill, hospitalized patients, which leads to higher case-fatality 
rates. A recent population-based case-control study from 
Brazil (29) showed that pulmonary involvement was the 
strongest independent predictive factor for death caused by 
severe leptospirosis. Pulmonary ﬁ  ndings were infrequent 
among case-patients in this study, the earlier Hawaii series 
(5), and the France series (27).
The changing temporal trend in the infecting sero-
group ﬁ  rst identiﬁ  ed in our earlier study has continued; 
most of the current leptospirosis isolates are in the Austra-
lis serogroup. This documented trend over the past 35 years 
from the previously predominant serogroup Icterohemor-
rhagiae to the now predominant Australis may reﬂ  ect the 
inﬂ  uence of different host animals, the effects of climatic 
and land use changes, or both. Serogroup Icterohemorrha-
giae has been associated with rats (Rattus norwegicus and 
R. rattus), and Australis has been associated with swine, 
including feral swine or wild boars (Sus scrofa) (30,31). 
Recent reports from Germany have shown high serop-
revalence of Australis serogroup (serovar Bratislava) in 
urban feral swine (32) and documented increased size in 
the feral swine population and habitat changes leading to 
epidemiologic linkages between leptospirosis occurrence 
and feral swine exposure (33). Hawaii has also experi-
enced an increase in the feral swine population, with a 
concordant sharp increase in the number of feral swine 
encroaching on urban residential areas (34,35). Research-
ers at the University of Hawaii are currently investigating 
the possible inﬂ  uence of feral swine exposure on human 
disease in Hawaii by undertaking a leptospirosis serop-
revalence study of feral swine.
Annual reported leptospirosis incidence rates in the 
United States ranged from 0.02 to 0.05 per 100,000 popu-
lation from 1974 through 1994, the last year leptospirosis 
was included in the list of nationally notiﬁ  able diseases (5). 
If we include probable and suspected cases, as was done 
nationally, our mean estimated annual incidence rate dur-
ing this 10-year study period would increase from 1.63 to 
2.85 per 100,000 population, ≈100× greater than that re-
ported nationally. Compared with other locales for which 
annual leptospirosis incidence rates are available, Ha-
waii would be considered in the moderate range category 
(1–10/100,000 population) (36). Countries in this range 
include Cuba (2.47/100,000 population) and Costa Rica 
(6.72/100,000 population) (3). Countries categorized as 
having high rates (>10/100,000 population) include Bar-
bados (10.03/100,000 population), Trinidad and Tobago 
(12.04/100,000 population), and Seychelles (43.21/100,000 
population) (3). Additional countries or regions considered 
to have high rates (for which data are not available) are 
Vietnam and French Polynesia (36). Although leptospirosis 
is a notiﬁ  able disease in Hawaii, case reporting is based on 
passive surveillance and likely underestimates true disease 
occurrence. During a 1-year period in 1988 and 1989, an 
active surveillance study was conducted on the islands of 
Hawaii and Kauai, which resulted in a 5-fold increase in 
case identiﬁ  cation (37). A recent retrospective analysis of 
serum obtained from febrile patients during a dengue fe-
ver outbreak in Hawaii, 2001–2002, also identiﬁ  ed a sub-
stantial number of leptospirosis cases that otherwise would 
have gone undiagnosed (38).
Conclusions
Future  ﬁ   eld studies using geographic information 
system technology to link climatic and environmental 
phenomena, such as rainfall occurrence and environmen-
tal isolates with human and animal infection, could offer 
valuable insights. Given the potential effects of climate and 
land use changes, public health ofﬁ  cials must remain alert 
to the occurrence and changing epidemiology of emerging 
and reemerging infectious diseases. Without national sur-
veillance, the occurrence of leptospirosis outside of Hawaii 
or other regions that have leptospirosis surveillance may 
go largely unrecognized, and thus, unmonitored. Ongoing 
surveillance activities, such as ecologic, animal, and labo-
ratory studies are necessary to clarify and track the dynam-
ic epidemiology of this widespread, reemerging zoonotic 
illness. 
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